Search results for "Fluoroquinolone"

showing 10 items of 47 documents

Anti- Toxoplasma Activities of 24 Quinolones and Fluoroquinolones In Vitro: Prediction of Activity by Molecular Topology and Virtual Computational Te…

2000

ABSTRACT The apicoplast, a plastid-like organelle of Toxoplasma gondii , is thought to be a unique drug target for quinolones. In this study, we assessed the in vitro activity of quinolones against T. gondii and developed new quantitative structure-activity relationship models able to predict this activity. The anti- Toxoplasma activities of 24 quinolones were examined by means of linear discriminant analysis (LDA) using topological indices as structural descriptors. In parallel, in vitro 50% inhibitory concentrations (IC 50 s) were determined in tissue culture. A multilinear regression (MLR) analysis was then performed to establish a model capable of classifying quinolones by in vitro acti…

medicine.drug_classStereochemistryMolecular ConformationBiologyModels BiologicalStructure-Activity RelationshipAnti-Infective AgentsPredictive Value of TestsMoxifloxacinparasitic diseasesmedicineAnimalsStructure–activity relationshipComputer SimulationPharmacology (medical)Mechanisms of Action: Physiological EffectsAntibacterial agentPharmacology4-QuinolonesBiological activityQuinoloneGatifloxacinGrepafloxacinTrovafloxacinInfectious DiseasesRegression AnalysisToxoplasmaFluoroquinolonesmedicine.drugAntimicrobial Agents and Chemotherapy
researchProduct

Comparison of Fluoroquinolones and Other Antibiotic Prophylaxis Regimens for Preventing Complications in Patients Undergoing Transrectal Prostate Bio…

2022

Our study aimed to compare the incidence of infective complications after transrectal ultrasound-guided prostate biopsy (TRUSBx) when adopting different antimicrobial prophylaxis regimens. A multi-institutional cohort of 1150 patients who underwent TRUSBx was retrospectively analyzed. Procedures were performed between 2017 and 2019 (before and after the EMA warning about the use of fluoroquinolones for the antibiotic prophylaxis of patient candidates to TRUSBx). The primary endpoint was the occurrence of infective complications, including sepsis and/or fever. The population was stratified according to the antibiotic prophylaxis adopted: fluoroquinolones (levofloxacin, ciprofloxacin, prulifl…

Microbiology (medical)Infectious Diseasesantibiotic prophylaxisantibiotic prophylaxis; fluoroquinolones; prostate biopsyantibiotic prophylaxiprostate biopsy; antibiotic prophylaxis; fluoroquinolonesPharmacology (medical)prostate biopsyfluoroquinolonesGeneral Pharmacology Toxicology and PharmaceuticsfluoroquinoloneBiochemistryMicrobiology
researchProduct

Typhoid Fever

2008

Typhoid fever continues to be a serious public health problem, with approximately 22. million cases and more than 200. 000 deaths globally. The disease is most often acquired by ingestion of food or water contaminated by the feces and less frequently by urine or vomitus of patients and carriers. Prolonged low-grade fever, headache, dry cough, alterations of bowel habits, coated tongue, and rose spots are the typical clinical features. Definitive diagnosis requires the isolation of Salmonella enterica serovar Typhi. Supportive serological tests are also used. First-choice antibiotic treatment includes fluoroquinolones or third-generation cephalosporins and reduces the mortality rate from 20%…

0301 basic medicine030106 microbiologyCephalosporinVi polysaccharide vaccineEnteric feverPeyer's patcheRose spotSalmonella typhiBlood cultureWaterborne03 medical and health sciencesTy21a0302 clinical medicineFluoroquinoloneTyphoid030212 general & internal medicineAgglutination testTyphoid FeverTyphoid fever
researchProduct

A topological substructural approach for the prediction of P-glycoprotein substrates

2006

A topological substructural molecular design approach (TOPS-MODE) has been used to predict whether a given compound is a P-glycoprotein (P-gp) substrate or not. A linear discriminant model was developed to classify a data set of 163 compounds as substrates or nonsubstrates (91 substrates and 72 nonsubstrates). The final model fit the data with sensitivity of 82.42% and specificity of 79.17%, for a final accuracy of 80.98%. The model was validated through the use of an external validation set (40 compounds, 22 substrates and 18 nonsubstrates) with a 77.50% of prediction accuracy; fivefold full cross-validation (removing 40 compounds in each cycle, 80.50% of good prediction) and the predictio…

Quantitative structure–activity relationshipMolecular modelLinear modelQuantitative Structure-Activity RelationshipPharmaceutical ScienceLinear discriminant analysisTopologyModels BiologicalData setSet (abstract data type)Pharmaceutical PreparationsPredictive Value of TestsTest setLinear ModelsComputer SimulationATP Binding Cassette Transporter Subfamily B Member 1Sensitivity (control systems)FluoroquinolonesMathematicsJournal of Pharmaceutical Sciences
researchProduct

Predominance of the fimH30 Subclone Among Multidrug-Resistant Escherichia coli Strains Belonging to Sequence Type 131 in Italy

2013

GeneticsSettore MED/07 - Microbiologia E Microbiologia ClinicaST131 E. coli fimH30 sub-clone in ItalyBiologymedicine.disease_causeAnti-Bacterial AgentsMicrobiologyMultiple drug resistanceInfectious DiseasesType (biology)Drug Resistance Multiple BacterialCorrespondenceEscherichia colimedicineHumansImmunology and AllergyEscherichia coliEscherichia coli InfectionsFluoroquinolonesSequence (medicine)Journal of Infectious Diseases
researchProduct

MALIGNANT EXTERNAL OTITIS. A CASE SERIES FROM AN ITALIAN TERTIARY-CARE HOSPITAL

2014

Objectives: Malignant external otitis (MEO) is an. aggressive and potentially fatal disease that affects the external. auditory canal (EAC) it occurs almost exclusively in elderly, diabetic patients or immune compromised ones. The aim of this study was to describe epidemiological and clinical characteristics of a consecutive series of patients affected by malignant external otitis (MEO) and to conceive a flow-chart for its management. Material and methods: Adult patients diagnosed with and treated for MEO at the University Hospital of Messina, Italy between 2003 and 2013 were identified. Charts were reviewed for history, clinical presentation, laboratory data treatment, and outcomes. Result…

Fluoroquinolones Malignant external otitis
researchProduct

The application of phospholipid removal columns and ultra-high performance liquid chromatography-tandem quadrupole mass spectrometry for quantificati…

2016

In this study a robust and sensitive method based on a proposed sample purification procedure, using zirconia-coated Phree™ columns and analysis by ultra-high performance liquid chromatography with triple quadrupole tandem mass spectrometry are presented for the assessment of multi-class antibiotics in farmed fish species. The sample preparation procedure benefited from combined precipitation of proteins and selective removal of phospholipids by Phree™ columns, resulting in a high sensitivity of the method (LOQ 0.3-9mgkg(-1)). The in-house validation results (precision, repeatability, decision limit CCα, detection capability CCβ, etc.) indicate that the elaborated method is fully suitable f…

Clinical BiochemistryPharmaceutical ScienceAquacultureTandem mass spectrometryMass spectrometry01 natural sciencesTrimethoprimAnalytical ChemistryTandem Mass SpectrometryDrug DiscoveryEnrofloxacinmedicinemedia_common.cataloged_instanceAnimalsSample preparationEuropean unionSpectroscopyChromatography High Pressure LiquidPhospholipidsmedia_commonEnrofloxacinChromatographyTandem010405 organic chemistryChemistry010401 analytical chemistryFishesReproducibility of ResultsRepeatabilityDrug Residues0104 chemical sciencesTriple quadrupole mass spectrometerAnti-Bacterial Agentsmedicine.drugFluoroquinolonesJournal of pharmaceutical and biomedical analysis
researchProduct

Extraintestinal pathogenic Escherichia coli sequence type 131 H30-R and H30-Rx subclones in retail chicken meat, Italy

2016

Extraintestinal pathogenic Escherichia coli sequence type 131 (ST131), typically fluoroquinolone-resistant (FQ-R) and/or extended-spectrum β-lactamase (ESBL)-producing, has emerged globally. Among clinical isolates, ST131, primarily its H30-R and H30-Rx subclones, accounts for most antimicrobial-resistant E. coli and is the dominant E. coli strain worldwide. We assessed its prevalence and characteristics among raw chicken meat samples on sale in Palermo, Italy. A collection of 237 fluoroquinolone resistant and ESBL/AmpC producing E. coli isolates, which had been isolated from processed retail chicken meat in the period May 2013-April 2015, was analyzed. Established polymerase chain reaction…

0301 basic medicineFimH30MeatAFLPST131Settore MED/17 - Malattie InfettiveAnimal foodExtraintestinal Pathogenic Escherichia colichicken030106 microbiologyBiologySettore MED/42 - Igiene Generale E ApplicataMicrobiologyH30-RxMicrobiologylaw.invention03 medical and health sciencesColi strainQuinolone resistanceChicken meatlawDrug Resistance BacterialAnimalsEscherichia coli sequence type 131Amplified Fragment Length Polymorphism AnalysisSafety Risk Reliability and QualityhumansPolymerase chain reactionPhylogenyExPECExtraintestinal Pathogenic Escherichia coliPhylogenetic treeGenetic heterogeneityE. coliGeneral Medicineβ-lactamaseItalyESBLFood MicrobiologyAFLP; Chicken meat; E. coli; ESBL; ExPEC; FimH30; H30-R; H30-Rx; ST131; Food Science; Microbiology; Safety Risk Reliability and QualityE.coliAmplified fragment length polymorphismChickensH30-RFluoroquinolonesPlasmidsFood Science
researchProduct

Drug Susceptibility Patterns in MDR-TB Patients: Challenges for Future Regimen Design. A Cross-Sectional Study

2015

Globally, there is substantial concern regarding the challenges of treating complex drug resistance patterns in multidrug resistant tuberculosis cases. Utilising data from three different settings (Estonia, Latvia, Romania) we sought to contrast drug susceptibility profiles for multidrug resistant tuberculosis cases, highlight the difficulties in designing universal regimen, and inform future regimen selection. Demographic and microbiological surveillance data for multidrug resistant tuberculosis cases from 2004-13 were analysed. High levels of additional resistance to currently recommended second line drugs were seen in all settings, with extensive variability between countries. Accurate d…

COUNTRIESEstoniaMaleDrug Resistance Multiple Bacterial/drug effectsFluoroquinolones/pharmacologyGeneral Science & TechnologyAntitubercular Agents/therapeutic useRomania/epidemiologyAntitubercular Agentslcsh:MedicineDrug Resistance Multiple BacterialMD MultidisciplinaryTuberculosis Multidrug-ResistantHumansMULTIDRUG-RESISTANT TUBERCULOSISlcsh:ScienceLatvia/epidemiologyDemographyScience & TechnologyRomanialcsh:REstonia/epidemiologyLatviaMultidisciplinary SciencesCross-Sectional StudiesScience & Technology - Other Topicslcsh:QFemaleTuberculosis Multidrug-Resistant/drug therapyResearch ArticleFluoroquinolonesPLoS ONE
researchProduct

Activity–Bioavailability balance in Oral Drug Development for a Selected Group of 6‐Fluoroquinolones

2002

Abstract A nomogram is proposed to select the best candidate in drug development studies with quinolones and is intended to substitute other possible models. The nomogram is referred to as an activity–bioavailability balance (ABB) because it includes the following two criteria: ABB= 1 / gm MIC ( drug candidate ) 1 /gm MIC ( ciprofloxacin ) · F calc \( drug candidate \) F calc ( ciproflaxacin ) . The in vitro activity of a group of 4′ N ‐alkyl‐ciprofloxacin derivatives was determined together with that of ciprofloxacin, initially against some reference strains and subsequently against 159 clinical isolates of eight selected species. The inverse of the geometric mean of the lowest concentrati…

ChemistryAdministration OralBiological AvailabilityPharmaceutical ScienceBiological activityMicrobial Sensitivity TestsPharmacologyAntimicrobialIntestinal absorptionRatsBioavailabilityCiprofloxacinStructure-Activity RelationshipMinimum inhibitory concentrationAnti-Infective AgentsDrug developmentmedicineAnimalsTechnology PharmaceuticalFluoroquinolonesAntibacterial agentmedicine.drugJournal of Pharmaceutical Sciences
researchProduct